Related Experiment Videos
Immunosuppressive effects of silicon phthalocyanine photodynamic therapy
J C Reddan1, C Y Anderson, H Xu
1Department of Otolaryngology, Case Western Reserve University, University Hospitals of Cleveland, OH, USA.
Abstract:
The purpose of this study was to determine if silicon phthalocyanine 4 (Pc 4), a second-generation photosensitizer being evaluated for the photodynamic therapy (PDT) of solid tumors, was immunosuppressive. Mice treated with Pc 4 PDT 3 days before dinitrofluorobenzene sensitization showed significant suppression of their cell-mediated immune response when compared to mice that were not exposed to PDT. The response was dose dependent, required both Pc 4 and light and occurred at a skin site remote from that exposed to the laser. The immunosuppression could not be reversed by in vivo pre-treatment of mice with antibodies to tumor necrosis factor-alpha or interleukin-10. These results provide evidence that induction of cell-mediated immunity is suppressed after Pc 4 PDT. Strategies that prevent PDT-mediated immunosuppression may therefore enhance the efficacy of this therapeutic modality.
Insights
Silicon phthalocyanine 4 (Pc 4) photodynamic therapy (PDT) significantly suppresses cell-mediated immunity in mice. This immunosuppression, observed remotely and dose-dependently, may impact therapeutic efficacy.
Area of Science:
- Immunology
- Photomedicine
- Oncology
Background:
- Photodynamic therapy (PDT) utilizes photosensitizers and light to treat solid tumors.
- Silicon phthalocyanine 4 (Pc 4) is a second-generation photosensitizer under investigation for PDT.
- The potential immunomodulatory effects of Pc 4 PDT require thorough investigation.
Purpose of the Study:
- To determine if silicon phthalocyanine 4 (Pc 4) photodynamic therapy (PDT) exhibits immunosuppressive properties.
- To assess the impact of Pc 4 PDT on the cell-mediated immune response in a preclinical model.
Main Methods:
- Mice were treated with Pc 4 PDT followed by dinitrofluorobenzene sensitization.
- Cell-mediated immune response was evaluated in treated versus untreated control groups.
- Dose-dependency and light-requirement of the response were assessed.
- In vivo experiments investigated the role of tumor necrosis factor-alpha and interleukin-10.
Main Results:
- Pc 4 PDT significantly suppressed the cell-mediated immune response.
- The observed immunosuppression was dose-dependent and required both Pc 4 and light.
- Immune suppression occurred at sites distant from the PDT treatment area.
- Pre-treatment with antibodies against TNF-alpha or IL-10 did not reverse the immunosuppression.
Conclusions:
- Pc 4 PDT induces immunosuppression, specifically inhibiting the induction of cell-mediated immunity.
- This immunosuppressive effect is independent of TNF-alpha and IL-10 pathways.
- Strategies to mitigate PDT-induced immunosuppression may be crucial for enhancing anti-tumor efficacy.